Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 14.18%
$768M
$124,000
0.0% of portfolio
36,888
Q3 2025
Reduced 14.12%
$85.6B
$868,000
0.0% of portfolio
68,639
Q3 2025
Added 42.29%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 2.44%
$575M
$221,000
0.0% of portfolio
19,402
Q3 2025
Reduced 16.85%
$917M
$380,000
0.0% of portfolio
9,416
Q3 2025
Reduced 15.94%
$4.04B
$2.02 Million
0.0% of portfolio
58,701
Q3 2025
Reduced 15.24%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 17.15%
$1.3B
$620,000
0.0% of portfolio
27,037
Q3 2025
Reduced 19.77%
$1.14B
$1.34 Million
0.0% of portfolio
56,910
Q3 2025
Reduced 0.05%
$879M
$411,000
0.0% of portfolio
57,772
Q3 2025
Reduced 15.21%
$8.87B
$300,000
0.0% of portfolio
7,369
Q3 2025
Added 90.32%
$350M
$68,000
0.0% of portfolio
5,266
Q3 2025
Reduced 16.12%
$1.59B
$910,000
0.0% of portfolio
79,799
Q3 2025
Reduced 20.69%
$4.04B
$1.9 Million
0.0% of portfolio
10,681
Q3 2025
Reduced 15.24%
$8.61B
$652,000
0.0% of portfolio
6,285
Q3 2025
Added 0.27%
$2.84B
$1.41 Million
0.0% of portfolio
108,517
Q3 2025
Reduced 7.56%
$76.6M
$41,000
0.0% of portfolio
43,510
Q3 2025
Reduced 14.67%
$1.47B
$565,000
0.0% of portfolio
145,270
Q3 2025
Reduced 10.67%
$3.81B
$1.81 Million
0.0% of portfolio
12,492
Q3 2025
Reduced 15.24%
$247M
$123,000
0.0% of portfolio
2,870
Q3 2025
Reduced 0.73%
$895M
$425,000
0.0% of portfolio
19,070
Q3 2025
Reduced 15.2%
$3.73B
$1.44 Million
0.0% of portfolio
24,783
Q3 2025
Reduced 15.23%
Ponce Financial Group Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 18.81%
-
$0
0.0% of portfolio
-
Q3 2025
New
$9.59B
$953,000
0.0% of portfolio
3,076
Q3 2025
Reduced 18.06%
$1.03B
$625,000
0.0% of portfolio
37,231
Q3 2025
Reduced 18.57%
$212M
$177,000
0.0% of portfolio
27,556
Q3 2025
Reduced 10.89%
$6.38B
$1.16 Million
0.0% of portfolio
10,779
Q3 2025
Added 23.27%
$292M
$165,000
0.0% of portfolio
10,498
Q3 2025
Reduced 14.54%
$491M
$198,000
0.0% of portfolio
11,667
Q3 2025
Reduced 16.54%
$3.18B
$1.48 Million
0.0% of portfolio
36,417
Q3 2025
Reduced 15.24%
$1.98B
$1.06 Million
0.0% of portfolio
26,356
Q3 2025
Reduced 15.23%
$1.33B
$300,000
0.0% of portfolio
3,042
Q3 2025
Reduced 15.26%
$181M
$900,000
0.0% of portfolio
180,553
Q3 2025
Reduced 12.39%
$22.8B
$2.7 Million
0.0% of portfolio
25,733
Q3 2025
Reduced 7.03%
$636M
$286,000
0.0% of portfolio
18,530
Q3 2025
Reduced 14.33%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 15.04%
Praxis Precision Medicines I
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 4.34%
$960M
$244,000
0.0% of portfolio
74,262
Q3 2025
Reduced 9.53%
$1.31B
$490,000
0.0% of portfolio
5,429
Q3 2025
Reduced 20.44%
$3.35B
$1.07 Million
0.0% of portfolio
38,326
Q3 2025
Reduced 23.55%
$2.99B
$1.43 Million
0.0% of portfolio
22,993
Q3 2025
Reduced 15.24%
$3.61B
$1.45 Million
0.0% of portfolio
11,932
Q3 2025
Reduced 15.23%
$323M
$667,000
0.0% of portfolio
120,423
Q3 2025
Added 0.47%
$267M
$25,000
0.0% of portfolio
157
Q3 2025
Reduced 43.12%
$269M
$108,000
0.0% of portfolio
10,341
Q3 2025
Reduced 10.24%
-
$0
0.0% of portfolio
-
Q3 2025
Added 48.74%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 14.75%
Priority Technology Hldgs In
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 17.09%